Navigation Links
Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study
Date:10/18/2010

ed to be included in the Intermezzo® NDA resubmission; Intermezzo® being the first commercially available sleep aid in the United States in its target indication; the ability of the highway driving study results to favorably differentiate Intermezzo® from other sleep aids and of Intermezzo® to become an important treatment option for patients; the sufficiency of Transcept cash resources to address the anticipated issues relating to the resubmission of the Intermezzo® NDA and to complete the planned Phase 2 study of TO-2061; and timing estimates to begin a Phase 2 study of TO-2061. Transcept may not actually achieve the plans, carry out the intentions or meet the expectations disclosed in our forward-looking statements and you should not place undue reliance on these forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements. Various important factors could cause actual results or events to differ materially from the forward-looking statements that Transcept makes, including the following: new information arising out of Intermezzo® clinical trial results, including the highway driving study, and the potential for the FDA's view of such data to differ from the Transcept interpretation; changing FDA guidance with respect to the driving study, proposed unit dose packaging for Intermezzo® and other aspects of the potential resubmission package for the Intermezzo® NDA; delays in the Intermezzo® approval process and the development progress of competitive products; the outcomes from planned Phase 1 studies of TO-2061 and discussions with the FDA about our development plans for TO-2061; the sufficiency of the anticipated content of the planned Intermezzo® NDA resubmission to support FDA approval; unforeseen expenses or delays in our currently planned d
'/>"/>
SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Transcept Pharmaceuticals to Host Conference Call to Discuss Preliminary Analysis of Intermezzo® Highway Driving Study
2. Transcept Pharmaceuticals to Present at Newsmakers in the Biotech Industry Conference
3. Transcept Pharmaceuticals to Present at BIO Investor Forum
4. Transcept Pharmaceuticals to Present at UBS Global Life Sciences Conference
5. Transcept Pharmaceuticals to Present at Rodman & Renshaw and Stifel Nicolaus Investor Conferences in September 2010
6. Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R)
7. Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo(R) Complete Response Letter
8. Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results
9. Transcept Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference on November 17
10. Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12
11. Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... June 29, 2015 Research ... the "Pharmaceutical Grade Sodium Chloride Market by Applications, ... report to their offering. The pharmaceutical ... CAGR of 6.9% between 2014 and 2019 in terms ... 690 KT by 2019. The report on ...
(Date:7/6/2015)... July 6, 2015 Moerae Matrix, a ... therapeutics that target inflammation and fibrosis, today announced ... PhD, as Chief Medical Officer. ... strategy and programs, which include a pipeline of ... fibrotic conditions.  Bill is an accomplished strategist and ...
(Date:7/6/2015)... 6, 2015 Celtaxsys, Inc., a clinical stage ... with rare and orphan inflammatory disease indications, announced today ... and Drug Administration (FDA) to begin a Phase 2 ... in adult CF patients in the US. The regulatory ... will be filed soon after. This groundbreaking ...
Breaking Medicine Technology:Global Pharmaceutical Grade Sodium Chloride Market Report 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 3Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3
... Inc. (NYSE: SMA ), a leading independent ... and other medical markets, announced a new management reporting ... to strengthen quality and customer service.  The Company,s implant, ... Thomas J. Sullivan, President and Chief Executive Officer. ...
... Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care ... its financial results for the fourth quarter and fiscal year ... 4:15 p.m. ET on Thursday, April 28, 2011.  The Company ... year 2011 after the market closes on Thursday, April 28, ...
Cached Medicine Technology:Symmetry Medical Centralizes Businesses Under CEO 2Symmetry Medical Centralizes Businesses Under CEO 3Symmetry Medical Centralizes Businesses Under CEO 4
(Date:7/6/2015)... ... July 06, 2015 , ... With a new community ... with Livonia Save Our Youth and announced a new charity campaign to raise funds ... to alcohol and drug abuse. Livonia Save Our Youth is a coalition created especially ...
(Date:7/6/2015)... ... July 06, 2015 , ... ... that Randstad Technologies selected Aspect Software Unified IP contact center solution hosted by ... selected Aspect Unified IP as its future call center platform. , Promero ...
(Date:7/6/2015)... , ... July 06, 2015 , ... The Path of ... into the economic transformation associated with the U.S. economy over the past 40 years. ... with its use. In many ways, the book is a time capsule that chronicles ...
(Date:7/5/2015)... ... July 05, 2015 , ... World Patent ... Master, a landscaping invention that effectively removes weeds without harming man and ... Scott Cooper, CEO and Creative Director of World Patent Marketing. "It is projected ...
(Date:7/4/2015)... ... July 04, 2015 , ... ... published the results of an annual member survey , detailing the most ... More recently, the group broke that raw data down into charts detailing demographic ...
Breaking Medicine News(10 mins):Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 2Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 3Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 3Health News:New Book Brings Reveals The Repercussions Associated With The Global Economy 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 4Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 5Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 2Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 3
... one in 500 Swedes carry a genetic mutation which can ... lifestyle changes, but quality of life can be maintained with ... the Sahlgrenska Academy at the University of Gothenburg, Sweden. ... children and adolescents is the heart muscle disease hypertrophic cardiomyopathy. ...
... its inception in 1998, TCAG has provided world-leading infrastructure ... of genomic disciplines, from human health to agriculture, food, ... based at The Hospital for Sick Children, is located ... including:, Gene and genome sequencing Microarrays and genotyping ...
... 1 (HealthDay News) -- Loneliness can be harmful to a ... Researchers examined levels of loneliness and sleep quality among ... was socially isolated, but those who had higher loneliness scores ... often during the night and were deemed to have what ...
... By Serena Gordon HealthDay Reporter , TUESDAY, Nov. 1 ... United States dropped slightly, to 12.2 percent in 2009, from its ... March of Dimes. , But those numbers fall far short ... explained Dr. Jennifer Howse, president of the March of Dimes. ...
... Island Hospital examined how the perception of roles among ... web survey with embedded interventions, the researchers were able ... patient satisfaction, while staff reported changing or reconsidering how ... published in the European Journal of Emergency Medicine ...
... people in Uganda live with HIV/AIDS, where long ... to treatment. By employing an innovative mobile-technology strategy, ... Lawson Health Research Institute, hopes to provide a ... own a mobile device. By leveraging this common ...
Cached Medicine News:Health News:Research supports broader screening for sudden cardiac death 2Health News:Loneliness Linked to Sleepless Nights 2Health News: U.S. Preterm Birth Rate Down Slightly 2Health News: U.S. Preterm Birth Rate Down Slightly 3Health News:How staff perceptions of their roles impact patients experience in the emergency department 2Health News:How staff perceptions of their roles impact patients experience in the emergency department 3
... For immobilization following shoulder fusion, dislocation, ... brace allows the shoulder to be ... rotation. Following brachial plexus injury this ... further stretch during the healing process ...
Unique V-lock strapping system prevents roll and shifting to provide secure shoulder immobilization...
Shoulder Subluxation Inhibitor (SSI) is an ideal bracing system to keep athletes on the field by reducing the risk of shoulder injury. The SSI is the only brace that allows TOTAL ANTERIOR RANGE OR MO...
... Bird and Cronin, ... manufacturer of Patient Footwear, ... Patient Care Products. Our ... highest quality and available ...
Medicine Products: